Harvinder Birk
Redding, CANPI 1417909854
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,545 of the $5,323 with a category attached, or 66.6%. It is spread thinly across 29 manufacturers, the largest accounting for just 20.0%. Reporting peaked in 2019 at $2,978 and has fallen 98.6% since, to $42 in 2021.
Across 220 payments — averaging $24.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Sanofi$1K
- EMD Serono, Inc.$484
- UCB, Inc.$313
- Biogen$301
- AbbVie$273
- plus $2K from 23 others
What the payments were for
- Consulting fees$1503%
- Speaking & faculty fees$72314%
- Travel & lodging$89117%
- Food & beverage$3,54567%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 9 | $1,065 |
| Sanofi | 19 | $1,028 |
| EMD Serono, Inc. | 25 | $484 |
| UCB, Inc. | 15 | $313 |
| Biogen | 9 | $301 |
| AbbVie(2 entities) | 20 | $273 |
| Teva Pharmaceuticals USA, Inc. | 26 | $239 |
| Neurocrine Biosciences, Inc. | 13 | $213 |
| Amgen | 8 | $192 |
| Novartis | 14 | $190 |
| Pfizer | 15 | $145 |
| Adamas Pharmaceuticals, Inc. | 7 | $135 |
| Assertio Therapeutics, Inc. | 6 | $85 |
| SK Life Science, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $73 |
| Acadia Pharmaceuticals Inc | 4 | $67 |
| Merck | 3 | $60 |
| Lundbeck LLC | 2 | $47 |
| Catalyst Pharmaceuticals, Inc. | 2 | $45 |
| Neurelis, Inc. | 2 | $44 |
| Upsher-smith Laboratories LLC | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| MDD US Operations, LLC | 2 | $34 |
| Genentech USA, Inc. | 2 | $25 |
| Acorda Therapeutics, Inc | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.